The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The efficacy of atezolizumab plus bevacizumab for advanced hepatocellular carcinoma in relation to tumor-infiltrating lymphocytes: Histological assessment of CD8+ T cell spatial features as predictive biomarkers.
 
Hiroaki Kanzaki
No Relationships to Disclose
 
Takamasa Ishino
No Relationships to Disclose
 
Sadahisa Ogasawara
Honoraria - AstraZeneca/Daiichi Sankyo; Chugai Pharma; Eisai; Merck
Consulting or Advisory Role - AstraZeneca; Chugai Pharma; Merck
Research Funding - AstraZeneca; Chugai Pharma; Eisai; Lilly
 
Midori Sawada
No Relationships to Disclose
 
Ryo Izai
No Relationships to Disclose
 
Takuya Yonemoto
No Relationships to Disclose
 
Sae Yumita
No Relationships to Disclose
 
Ryuta Kojima
No Relationships to Disclose
 
Keisuke Koroki
No Relationships to Disclose
 
Masanori Inoue
No Relationships to Disclose
 
Naoya Kanogawa
No Relationships to Disclose
 
Yuka Takano
No Relationships to Disclose
 
Kaho Takata
No Relationships to Disclose
 
Masahito Kawazu
No Relationships to Disclose
 
Junichiro Ikeda
No Relationships to Disclose
 
Masayuki Ohtsuka
Speakers' Bureau - Abbvie; AMCO; Astellas Pharma; AstraZeneca; Chugai Pharma; Incyte; Japan Blood Products Organization; Miyarisan Pharmaceutical; MSD; Nipro Corporation; Otsuka; Tsumura & Co.; Viatris; Yakult Pharmaceutical
Research Funding - Asahi Kasei; Chugai Pharma; Japan Blood Products Organization; Kaken Pharmaceutical; Taiho Pharmaceutical
 
Yujin Hoshida
Stock and Other Ownership Interests - Alentis Therapeutics; Espervita Therapeutics
Consulting or Advisory Role - Elevar Therapeutics; Espervita Therapeutics; Helio Genomics; Roche Diagnostics Solutions
 
Mina Komuta
Honoraria - Eisai
 
Yosuke Togashi
Honoraria - AstraZeneca; Bristol-Myers Squibb Japan; Chugai Pharma; Eisai; MSD K.K; Ono Pharmaceutical
Consulting or Advisory Role - Sonire Therapeutics
Research Funding - AstraZeneca (Inst); AstraZeneca (Inst); Daiichi Sankyo/UCB Japan (Inst); Janssen (Inst); KORTUC (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst)